About Inosan
Inosan is a company based in Madrid (Spain) founded in 2012 by Juan Lopez de Silanes Blanco. It operates as a B2B and D2C. Inosan offers products and services including Inoserp MENA, Inoserp PAN-AFRICA, and Inoscorpi MENA. Inosan operates in a competitive market with competitors including Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
- Headquarter Madrid, Spain
- Founders Juan Lopez de Silanes Blanco
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inosan Biopharma
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inosan
Inosan offers a comprehensive portfolio of products and services, including Inoserp MENA, Inoserp PAN-AFRICA, and Inoscorpi MENA.
Polyvalent antivenom for treating snake bites in Middle East and North Africa
Polyvalent antivenom for Sub-Saharan African snake bites
Polyvalent antivenom for scorpion stings in Middle East and North Africa
Funding Insights of Inosan
Detailed funding history for Inosan
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inosan
Investment portfolio details for Inosan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inosan
Detailed financials for Inosan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inosan Comparisons
Peer comparison for Inosan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inosan
Inosan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for immunological and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Plasma-derived therapies are developed to treat multiple diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
Detailed competitors of Inosan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inosan
Complete news archive for Inosan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inosan
Inosan was founded in 2012.
Inosan is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Juan Lopez de Silanes Blanco is the current CEO of Inosan. They have also founded this company.
Inosan Biopharma is a biotechnology company that focuses on innovating and producing high-purity antivenoms for treating bites from venomous animals, targeting rare and neglected diseases. They align with WHO strategies for global disease control through research, development, and distribution. Operating from Spain and Mexico, they serve health organizations in Africa and the Middle East, emphasizing safety and efficacy in their products.
Inosan's top competitors include ADMA Biologics, BioNTech and Generate Biomedicines.
Inosan offers Inoserp MENA, Inoserp PAN-AFRICA, and Inoscorpi MENA.